Dr. Moshfeghi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1450 San Pablo St
Fl 4
Los Angeles, CA 90033Phone+1 323-442-6335Fax+1 323-442-6412
Summary
- Dr. Andrew Moshfeghi is an ophthalmologist in Los Angeles, CA and is affiliated with multiple hospitals in the area, including Keck Hospital of USC and LAC+USC Medical Center. He received his medical degree from Tulane University School of Medicine and has been in practice 18 years. He also speaks multiple languages, including Spanish. He specializes in retinal disease and is experienced in diabetes mellitus, intravitreal injection, retinopathy of prematurity, macular degeneration, and macular edema.
Education & Training
Zucker School of Medicine at Hofstra/NorthwellResidency, Ophthalmology, 2000 - 2003
MetroWest Medical CenterInternship, Transitional Year, 1999 - 2000
Tulane University School of MedicineClass of 1999
Certifications & Licensure
CA State Medical License 2015 - 2026
FL State Medical License 2003 - 2021
KY State Medical License 2013 - 2020
WV State Medical License 2013 - 2015
NY State Medical License 2000 - 2004- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Pasadena Top Doctor Pasadena Magazine, 2023
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013
- Join now to see all
Clinical Trials
- A Scan Ultrasonography in the Evaluation of Retinopathy of Prematurity Start of enrollment: 2010 Oct 01
- Ocriplasmin Research to Better Inform Treatment (ORBIT) Start of enrollment: 2014 May 01
- Evaluation of Bromocriptine, Metoprolol and Tamsulosin in Eyes With Non-Central DME Start of enrollment: 2018 Mar 01
Publications & Presentations
PubMed
- 1 citationsImpact of anti-VEGF treatment on development of proliferative diabetic retinopathy in routine clinical practice.Andrew A Moshfeghi, Rahul N Khurana, Hadi Moini, Steven Sherman, Kimberly Reed
BMC Ophthalmology. 2024-05-31 - Comparison of The Results of Sponsored Genetic Testing Panels for Inherited Retinal Diseases.Yicheng K Bao, Betty A Situ, Margaret Runner, Andrew Moshfeghi, Hossein Ameri
Journal of Clinical Medicine. 2024-05-26 - 7 citationsEpidemiology of rhegmatogenous retinal detachment in commercially insured myopes in the United States.Cassie A Ludwig, Daniel Vail, Ahmad Al-Moujahed, Natalia F Callaway, Namrata Saroj
Scientific Reports. 2023-06-09
Press Mentions
Ocular Therapeutix Announces Interim Data from the Ongoing US Phase 1 Trial Evaluating OTX-TKI for the Treatment of Wet AMDFebruary 13th, 2023
Five-Year Patterns of Diabetic Retinopathy Progression in US Clinical PracticeOctober 29th, 2020
Predictive Value of the OCT Double-Layer Sign for Identifying Subclinical Neovascularization in Age-Related Macular DegenerationOctober 30th, 2019- Join now to see all
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
